Search the Community
Showing results for tags 'hypopituitarism'.
Found 6 results
-
In patients with Cushing’s disease, removing the pituitary tumor via an endoscopic transsphenoidal surgery (TSS) leads to better remission rates than microscopic TSS, according to new research. But regardless of surgical approach, plasma cortisol levels one day after surgery are predictive of remission, researchers found. The study, “Management of Cushing’s disease: Changing trend from microscopic to endoscopic surgery,” was published in the journal World Neurosurgery. Because it improves visualization and accessibility, endoscopic TSS has been gaining popularity over microscopi -
LOS ANGELES — More than a century has passed since the neurosurgeon and pathologist Harvey Cushing first discovered the disease that would eventually bear his name, but only recently have several key discoveries offered patients with the condition real hope for a cure, according to a speaker here. There are several challenges clinicians confront in the diagnosis and treatment of Cushing’s disease, Shlomo Melmed, MB, ChB, FRCP, MACP, dean, executive vice president and professor of medicine at Cedars-Sinai Medical Center in Los Angeles, said during a plenary presentation. Patients who prese
- 3 replies
-
- 1
-
-
- dr. shlomo melmed
- radiation
- (and 3 more)
-
A man with Cushing’s disease — caused by an adrenocorticotrophic hormone (ACTH)-secreting pituitary adenoma — who later developed metastases in the central nervous system without Cushing’s recurrence, was successfully treated over eight years with radiation and chemotherapy, according to a case report. The report, “Long-term survival following transformation of an adrenocorticotropic hormone secreting pituitary macroadenoma to a silent corticotroph pituitary carcinoma: Case report,” was published in the journal World Neurosurgery. Pituitary carcinomas make up only 0.1-0.2% of all pit
-
- 1
-
-
- cushings disease
- pituitary carcinoma
- (and 4 more)
-
Dr. Theodore Friedman’s next webinar will be on the Macrilen Stimulation Test for Growth Hormone Deficiency: Sunday, December 9, 2018, 6 PM PST Adult growth hormone deficiency occurs in patients with hypopituitarism and can occur in those with a pituitary tumor. A growth hormone stimulation test is needed to make the diagnosis of adult growth hormone deficiency. Dr. Theodore Friedman’s next webinar will be on the Macrilen Stimulation Test for Growth Hormone Deficiency: Sunday, December 9, 2018, 6-7 PM PST. He will discuss the new Macrilen stimulation test and compare it to th
-
- 1
-
-
- dr. theodore friedman
- dr. f
- (and 5 more)
-
Webinar: Oxytocin and Hypopituitarism: A Missing Forgotten Hormone?
MaryO posted a calendar event in Cushie Calendar
untilThursday May 31, 2018 1:00 PM - 2:00 PM EDT Presented by Yuval Eisenberg, MD Assistant Professor of Medicine University of Illinois, at Chicago (UIC) Division of Endocrinology, Diabetes and Metabolism Webinar Description Learning Objectives: 1) Review the functions of oxytocin in humans 2) Describe areas of active research on oxytocin effects 3) Review the relevant oxytocin and hypopituitarism literature Presenter Bio Dr. Yuval Eisenberg is an endocrinologist at the University of Illinois, at Chicago (UIC). Dr. Eisenberg studied Medicine at Rush Medical -
Thursday May 31, 2018 1:00 PM - 2:00 PM EDT Presented by Yuval Eisenberg, MD Assistant Professor of Medicine University of Illinois, at Chicago (UIC) Division of Endocrinology, Diabetes and Metabolism Webinar Description Learning Objectives: 1) Review the functions of oxytocin in humans 2) Describe areas of active research on oxytocin effects 3) Review the relevant oxytocin and hypopituitarism literature Presenter Bio Dr. Yuval Eisenberg is an endocrinologist at the University of Illinois, at Chicago (UIC). Dr. Eisenberg studied Medicine at Rush Medical
